Guardant Health Inc (NASDAQ: GH) is -24.18% lower on its value in year-to-date trading and has touched a low of $15.81 and a high of $37.04 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GH stock was last observed hovering at around $20.20 in the last trading session, with the day’s gains setting it 0.31%.
Currently trading at $20.51, the stock is -3.61% and -13.76% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.4 million and changing 1.53% at the moment leaves the stock -14.71% off its SMA200. GH registered -22.13% loss for a year compared to 6-month gain of 19.52%. The firm has a 50-day simple moving average (SMA 50) of $23.7826 and a 200-day simple moving average (SMA200) of $24.0292.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -9.77% loss in the last 1 month and extending the period to 3 months gives it a -41.87%, and is -4.07% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.64% over the week and 3.38% over the month.
Guardant Health Inc (GH) has around 1779 employees, a market worth around $2.52B and $643.81M in sales. Profit margin for the company is -76.23%. Distance from 52-week low is 29.73% and -44.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.41%).
with sales reaching $170.62M over the same period.The EPS is expected to grow by 23.98% this year, but quarterly earnings will post 23.30% year-over-year. Quarterly sales are estimated to grow 19.30% in year-over-year returns.
Guardant Health Inc (GH) Top Institutional Holders
401.0 institutions hold shares in Guardant Health Inc (GH), with institutional investors hold 104.67% of the company’s shares. The shares outstanding are 121.63M, and float is at 117.72M with Short Float at 11.62%. Institutions hold 99.88% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 11.64 million shares valued at $336.07 million. The investor’s holdings represent 9.5609% of the GH Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.24 million shares valued at $324.55 million to account for 9.2332 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 6.09 million shares representing 5.0063% and valued at over $175.97 million, while DEEP TRACK CAPITAL, LP holds 3.6973 of the shares totaling 4.5 million with a market value of $129.96 million.
Guardant Health Inc (GH) Insider Activity
The most recent transaction is an insider sale by Joyce Meghan V., the company’s Director. SEC filings show that Joyce Meghan V. sold 100 shares of the company’s common stock on Jun 04 ’24 at a price of $27.87 per share for a total of $2787.0. Following the sale, the insider now owns 4621.0 shares.
Guardant Health Inc disclosed in a document filed with the SEC on Mar 18 ’24 that Kalia Kumud (Chief Information Officer) bought a total of 2,187 shares of the company’s common stock. The trade occurred on Mar 18 ’24 and was made at $17.82 per share for $38963.0. Following the transaction, the insider now directly holds 12722.0 shares of the GH stock.
Still, SEC filings show that on Mar 04 ’24, Joyce Meghan V. (Director) disposed off 100 shares at an average price of $19.05 for $1905.0. The insider now directly holds 4,521 shares of Guardant Health Inc (GH).
